Showing results (41-50 of 293) with videos related to

Sort By:
Pageof 30
Applied Health Economics and Health Policy|March 1, 2016
Using Phase-Based Costing of Real-World Data to Inform Decision-Analytic Models for Atrial FibrillationAmy Tawfik, Walter P Wodchis, Petros Pechlivanoglou, et al.
International Journal of Technology Assessment in Health Care|May 9, 2014
Health technology assessment and personalized medicine: are economic evaluation guidelines sufficient to support decision making?Don Husereau, Deborah A Marshall, Adrian R Levy, et al.
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|January 7, 2026
Points to consider for incorporating climate impacts into health economic evaluationJule Oldenburg, Oliver Lange, Mattis Keil, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 2009
Cost effectiveness of ixabepilone plus capecitabine for metastatic breast cancer progressing after anthracycline and taxane treatmentShelby D Reed, Yanhong Li, Kevin J Anstrom, et al.
International Journal of Technology Assessment in Health Care|July 17, 2003
Comparison of hospital costing methods in an economic evaluation of a multinational clinical trialShelby D Reed, Joëlle Y Friedman, Ari Gnanasakthy, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|November 2, 2018
INITIAL ADOPTION OF RECOMBINANT HUMAN THYROID-STIMULATING HORMONE FOLLOWING THYROIDECTOMY IN THE MEDICARE THYROID CANCER PATIENT POPULATIONMichaela A Dinan, Yanhong Li, Shelby D Reed, et al.
The Patient|January 31, 2024
Stated-Preference Survey Design and Testing in Health ApplicationsDeborah A Marshall, Jorien Veldwijk, Ellen M Janssen, et al.
The Annals of Pharmacotherapy|January 31, 2002
Economic issues and antibiotic resistance in the communityShelby D Reed, Ramanan Laxminarayan, Doug J Black, et al.
Health Services Research|August 11, 2015
Patient Preferences for Features of Health Care Delivery Systems: A Discrete Choice ExperimentAxel C Mühlbacher, Susanne Bethge, Shelby D Reed, et al.
Pharmacoeconomics|April 24, 2008
Updated estimates of survival and cost effectiveness for imatinib versus interferon-alpha plus low-dose cytarabine for newly diagnosed chronic-phase chronic myeloid leukaemiaShelby D Reed, Kevin J Anstrom, Yanhong Li, et al.
Pageof 30